Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hydroxyapatite assay to measure epidermal growth factor receptor in human primary breast tumors.

× No keyword cloud information.

14 in total

1. Epidermal growth factor receptor gene expression and binding capacity in renal cell carcinoma, in relation to tumor stage, grade and DNA ploidy.

Authors: B Ljungberg; M Gåfvels; J E Damber
Journal: Urol Res Date: 1994

2. Changes in oestrogen, progesterone and epidermal growth factor receptor concentrations and affinities during the oestrous cycle in the normal mammary gland and uterus of dogs.

Authors: I Donnay; P Wouters-Ballman; N Devleeschouwer; G Leclercq; J Verstegen
Journal: Vet Res Commun Date: 1995 Impact factor: 2.459

3. Lack of prognostic value of epidermal growth factor receptor in a series of 229 T1/T2, N0/N1 breast cancers, with well defined prognostic parameters.

Authors: M Bolla; M Chedin; M Colonna; J Marron-Charrière; B Rostaing-Puissant; D Pasquier; M H Panh; P Winckel; E M Chambaz
Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872

4. Epidermal growth factor receptor levels increase but epidermal growth factor receptor ligand levels decrease in mouse mammary tumors during progression from hormone dependence to hormone independence.

Authors: C B Kienhuis; M Sluyser; C C de Goeij; P G Koenders; T J Benraad
Journal: Breast Cancer Res Treat Date: 1993 Impact factor: 4.872

5. Endogenous ligands for the epidermal growth factor receptor in human breast tumors do not interfere in an epidermal growth factor receptor radioligand binding assay.

Authors: C B Kienhuis; P G Koenders; H Klominska; T J Benraad
Journal: Breast Cancer Res Treat Date: 1993-09 Impact factor: 4.872

6. Expression of epidermal growth factor receptor (EGFR) in non-affected and tumorous mammary tissue of female dogs.

Authors: G R Rutteman; J A Foekens; H Portengen; J H Vos; M A Blankenstein; E Teske; C J Cornelisse; W Misdorp
Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872

7. Somatostatin receptors in differentiated ovarian tumors.

Authors: J C Reubi; U Horisberger; J G Klijn; J A Foekens
Journal: Am J Pathol Date: 1991-05 Impact factor: 4.307

8. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study.

Authors: J G Klijn; M P Look; H Portengen; J Alexieva-Figusch; W L van Putten; J A Foekens
Journal: Breast Cancer Res Treat Date: 1994-01 Impact factor: 4.872

9. Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry.

Authors: T van Agthoven; M Timmermans; J A Foekens; L C Dorssers; S C Henzen-Logmans
Journal: Am J Pathol Date: 1994-06 Impact factor: 4.307

10. Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment.

Authors: J E Damber; A Bergh; B Assarsson; M Gåfvels
Journal: Urol Res Date: 1995